Psyence Biomedical
11 hedge funds and large institutions have $1.53M invested in Psyence Biomedical in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 6 closing their positions.
663% more capital invested
Capital invested by funds: $201K → $1.53M (+$1.33M)
0% more funds holding
Funds holding: 11 → 11 (0)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
3.74% less ownership
Funds ownership: 22.91% → 19.18% (-3.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$1.82M |
| 2 |
EP
Essential Planning
Portsmouth,
New Hampshire
|
+$350K |
| 3 |
HF
HRT Financial
New York
|
+$123K |
| 4 |
VF
Virtu Financial
New York
|
+$60.8K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$59.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CF
Cantor Fitzgerald
New York
|
-$33.7K |
| 2 |
SFFS
Stonehage Fleming Financial Services
St. Helier,
Jersey
|
-$8.05K |
| 3 |
Morgan Stanley
New York
|
-$4.84K |
| 4 |
Jane Street
New York
|
-$4.6K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$1.5K |
PBM Hedge Fund Activity: Q4 2024 in Review
11 of the 7,612 institutional investors tracked by Wall St. Rank reported a position in Psyence Biomedical (PBM) for Q4 2024, worth a combined $1.53M — up 663% from $201K a quarter earlier.
Fund positioning in PBM was balanced in Q4 2024: 6 funds opened new positions, 6 closed out, 5 added to existing stakes and 0 trimmed.
The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $1.82M. The largest seller was Cantor Fitzgerald, exiting entirely with an estimated $33.7K sold.
- 11 institutional investors held Psyence Biomedical (PBM) as of Q4 2024, unchanged from Q3 2024.
- Funds reported $1.53M of Psyence Biomedical stock for Q4 2024, up 663% quarter-over-quarter.
- 6 funds opened new Psyence Biomedical positions in Q4 2024 and 6 closed out, a net change of 0 holders.
- The largest Psyence Biomedical buyer in Q4 2024 was Hudson Bay Capital Management, an estimated $1.82M added.
- The largest Psyence Biomedical seller in Q4 2024 was Cantor Fitzgerald, an estimated $33.7K sold.
Based on aggregated 13F filings for Q4 2024.